Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-098 manufacturers

Filters

1 products found

pp-098

Gel

Dossier type
CTD
Dossier status
Under development
Country of origin
Israel
Comments
Indication: Keratinization disorders including pachyonychia congenita and other hyperkeratosis‑related skin diseases in adults and pediatric populations as appropriate Clinical stage: Early clinical development — Phase 1b proof‑of‑concept completed / ongoing exploration with potential Phase 2 plans and feasibility studies Modality: Small molecule (tyrosine kinase inhibitor) in topical form Mechanism / Target: Inhibitor of epidermal growth factor receptor (EGFR), aiming to reduce epidermal hyperproliferation and abnormal keratinization Route / form: Topical gel formulation designed for direct skin application Differentiation: First topical erlotinib formulation optimized for higher local concentration with minimal systemic exposure, intended to address rare hyperkeratosis conditions that lack approved targeted therapies
Manufacturer #38928

Clinical-stage biotechnology company developing targeted topical therapies for rare dermatologic conditions. Focuses on hedgehog pathway inhibitors to prevent basal cell carcinoma lesions. Strategy emphasizes global clinical trials and future commercialization partnerships.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.